Cargando…
Correction to: Gadoxetic acid‑enhanced MRI in primary sclerosing cholangitis: added value in assessing liver function and monitoring disease progression
Autores principales: | Elkilany, Aboelyazid, Geisel, Dominik, Müller, Tobias, Fischer, Andreas, Denecke, Timm |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8502145/ https://www.ncbi.nlm.nih.gov/pubmed/34223963 http://dx.doi.org/10.1007/s00261-021-03155-z |
Ejemplares similares
-
Gadoxetic acid-enhanced MRI in primary sclerosing cholangitis: added value in assessing liver function and monitoring disease progression
por: Elkilany, Aboelyazid, et al.
Publicado: (2020) -
A radiomics-based model to classify the etiology of liver cirrhosis using gadoxetic acid-enhanced MRI
por: Elkilany, Aboelyazid, et al.
Publicado: (2021) -
Percutaneous transluminal angioplasty for symptomatic hepatic vein-type Budd-Chiari syndrome: feasibility and long-term outcomes
por: Elkilany, Aboelyazid, et al.
Publicado: (2022) -
MR imaging of hepatocellular carcinoma: prospective intraindividual head-to-head comparison of the contrast agents gadoxetic acid and gadoteric acid
por: Collettini, Federico, et al.
Publicado: (2022) -
Correction to: Impact of interventionalist’s experience and gender on radiation dose and procedural time in CT-guided interventions—a retrospective analysis of 4380 cases over 10 years
por: Theilig, Dorothea, et al.
Publicado: (2021)